VanEck Pharmaceutical ETF (PPH) News Today $86.59 -1.58 (-1.79%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNROctober 17, 2024 | finance.yahoo.comDiversified Exposure To The Weight Loss Drug MarketOctober 10, 2024 | seekingalpha.comPharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPHOctober 3, 2024 | seekingalpha.comAbbVie stock analysis: Rinvoq and Skyrizi are big catalystsOctober 1, 2024 | msn.comThis Canadian ETF could be a play on the changing fortunes of U.S. Mid-CapsSeptember 20, 2024 | theglobeandmail.comTeva Pharmaceutical hits a new 52-week highAugust 14, 2024 | msn.comPPH: A Strong Fund To Play Big PharmaJuly 18, 2024 | seekingalpha.comJust Say No to Drugs: 3 Pharma Stocks to AvoidMay 8, 2024 | msn.comPPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total ReturnsApril 23, 2024 | seekingalpha.comCanada’s updated guidance on ESG-related investment fund disclosureApril 18, 2024 | theglobeandmail.comVanEck Pharmaceutical ETF declares quarterly distribution of $0.5328April 3, 2024 | msn.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328April 1, 2024 | msn.comThe Top 3 ETFs to Buy in March 2024March 7, 2024 | investorplace.com11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher YieldsFebruary 28, 2024 | markets.businessinsider.comNavigate to Success With These 4 Pharma Stocks to BuyFebruary 28, 2024 | stocknews.comThe 3 Hottest Healthcare ETFs to Buy in 2024February 26, 2024 | investorplace.comPPH VanEck Pharmaceutical ETFFebruary 21, 2024 | seekingalpha.comHealthcare dealmakers see increased M&A, valuations in 2024: KPMGFebruary 20, 2024 | msn.comBig Pharma earnings season in spotlight amid positive sentimentJanuary 28, 2024 | msn.com5 ETF Zones Scaling New Highs at the Start of 2024January 8, 2024 | finance.yahoo.comPfizer in 2024: What to expect?December 29, 2023 | msn.comGilead in 2024: What to expect?December 28, 2023 | msn.comVanEck Pharmaceutical ETF Announces Dividend of $0.31 (NASDAQ:PPH)VanEck Pharmaceutical ETF (NASDAQ:PPH) announced a dividend on Tuesday, December 26th. Investors of record on Thursday, December 28th will be given a dividend of 0.3074 per share on Friday, December 29th. The ex-dividend date is Wednesday, December 27th.December 27, 2023 | marketbeat.comVontobel Holding Ltd. Has $799,000 Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)Vontobel Holding Ltd. trimmed its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH - Free Report) by 78.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,000 shares of the company's stock after selling 36,000 sDecember 26, 2023 | marketbeat.comETFs to buy and sell as the GLP-1 craze boomsDecember 6, 2023 | cnbc.com10 Best Performing Healthcare ETFs in 2023November 14, 2023 | uk.finance.yahoo.comPharma to Farmers: My 3 Favorite “Essential” ETFs To Consider Adding To Your PortfolioNovember 6, 2023 | msn.comPPH ETF Stock Price HistoryNovember 1, 2023 | investing.comPPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling PortfolioOctober 29, 2023 | msn.com3 Resilient Pharma Stocks to Buy This WeekOctober 26, 2023 | stocknews.comOzempic craze drives big flows into pharmaceutical, Danish fundsOctober 25, 2023 | msn.comEli Lilly, Novo among notable decliners in pharma weaknessOctober 19, 2023 | seekingalpha.comWhich of these 3 Pharma Stocks Should You Buy, Hold or Sell?September 15, 2023 | stocknews.comHRT Financial LP Increases Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)HRT Financial LP grew its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH - Free Report) by 1,225.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 67,098 shares of the company's stock after buying an additional 62,036 shares during the period. HRT FinaSeptember 4, 2023 | marketbeat.comWhy is big pharma unmoved despite Medicare pricing threat?September 3, 2023 | msn.comShort Interest in VanEck Pharmaceutical ETF (NASDAQ:PPH) Drops By 17.0%VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 2,000,000 shares, a decrease of 17.0% from the July 31st total of 2,410,000 shares. Based on an average daily volume of 127,800 shares, the short-interest ratio is presently 15.6 days.August 28, 2023 | marketbeat.comPharma ETF (PPH) Hit a 52-Week HighAugust 11, 2023 | au.news.yahoo.comRaymond James & Associates Cuts Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)Raymond James & Associates trimmed its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH - Free Report) by 77.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,706 shares of the company's stock after selling 23,3July 27, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Trims Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)Raymond James Financial Services Advisors Inc. trimmed its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH - Free Report) by 87.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,762 shares of the compaJuly 24, 2023 | marketbeat.comPPH - VanEck Pharmaceutical ETFJuly 6, 2023 | finance.yahoo.comInternational Assets Investment Management LLC Makes New Investment in VanEck Pharmaceutical ETF (NASDAQ:PPH)International Assets Investment Management LLC acquired a new stake in VanEck Pharmaceutical ETF (NASDAQ:PPH - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 1,708 shares of the company's stock, valued atJuly 4, 2023 | marketbeat.comSanofi: EPS Momentum Driven By Dupixent, Vaccines Day On TapJune 29, 2023 | msn.comVanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Acquired by Vontobel Holding Ltd.Vontobel Holding Ltd. lifted its position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 78.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 41,000 shares of the company's stock after buying an additional 1June 26, 2023 | marketbeat.comETFs to Capitalize on Eli Lilly's Buyout of DICE TherapeuticsJune 21, 2023 | msn.comAlerus Financial NA Invests $3.69 Million in VanEck Pharmaceutical ETF (NASDAQ:PPH)Alerus Financial NA purchased a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 47,420 shares of the company's stock, valuedJune 13, 2023 | marketbeat.comHRT Financial LP Sells 40,941 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)HRT Financial LP trimmed its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 89.0% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 5,062 shares of the company's stock after selling 40,941 shares during the quarter. HRT FinanJune 6, 2023 | marketbeat.com2,923 Shares in VanEck Pharmaceutical ETF (NASDAQ:PPH) Purchased by Miller Investment Management LPMiller Investment Management LP acquired a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,923 shaJune 2, 2023 | marketbeat.comVanEck Pharmaceutical ETF (NASDAQ:PPH) Stock Holdings Lessened by Phoenix Holdings Ltd.Phoenix Holdings Ltd. lowered its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 0.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,195,008 shares of the company's stock afMay 29, 2023 | marketbeat.comVanEck ETF Trust - VanEck Pharmaceutical ETF (NASDAQ: PPH)May 26, 2023 | fool.comRaymond James Financial Services Advisors Inc. Increases Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)Raymond James Financial Services Advisors Inc. increased its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 586.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,364 shares of the company's stock afterMay 26, 2023 | marketbeat.com Get VanEck Pharmaceutical ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now PPH Media Mentions By Week PPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PPH News Sentiment▼0.940.97▲Average Manufacturing News Sentiment PPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PPH Articles This Week▼10▲PPH Articles Average Week Get VanEck Pharmaceutical ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PSCH News BIB News IBBQ News BIS News IBB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PPH) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
